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Diabetes Mellitus Type II Quality Improvement Using the 
My Own Health Report
Lynn B. McMorrow MS, APRN, FNP-C
Introduction
• 1980-2012,  adults with diabetes 
in the US rose from 5.5 million to 
21.3 million
• 1.7 million more  are diagnosed 
yearly 
• 176 billion in estimated direct 
medical costs in 2012
• 69 million in lost wages, disability 
and death in 2012
• Patient self-management has 
been shown to improve patient 
quality of life, and short term 
glycemic control 
• My Own Health Report (MOHR) 
is an on-line health risk 
assessment tool to assess patient 
behaviors,  mental health risks
• Patients identify readiness to 
change, & willingness to discuss 
changes with their provider 
Purpose
Develop a new QI process  for 
Type 2 Diabetes (T2D) using the
MOHR
Aims
• Develop QI process, with 
the MOHR for T2D with 
HbA1C >9
• Expect statistically 
significant improvement in 
HbA1c and or weight over 6 
months, in the MOHR 
group  vs. the non-MOHR 
group
Methods
• QI process began with 27 patients  
• 10 patients  did not participate and 
17  did the MOHR
• MOHR administered by the medical 
assistant in 5-10 minutes
• Provider reviewed the MOHR 
summary and used motivational 
interviewing (MI) to discuss the 
results with each patient at a T2D 
visit, for willingness to discuss or 
change modifiable life styles. 
• Quantitative analysis  done with 
Fisher’s Exact Test comparing those 
who were in the MOHR group to 
those not participating. 
• Qualitative analysis was not done 
secondary to time and EHR 
constraints.
Results
• Quantitative: Comparison of the 
MOHR group to the non-MOHR 
group: 47% improved both weight 
and HbA1c whereas the non-MOHR 
group had 0% improvement  
(P=0.01). 
• Using the same comparison for 
HbA1c only, the MOHR group 
decreased by 58% compared to 
10% for the non-MOHR group 
(P= 0.02)
• There was no statistical 
improvement in weight alone or in
keeping appointments
Results
•Qualitative analysis was to be 
measured by a patient survey but 
time constraints prevented the 
survey from being completed. All 
patient comments are presented, 
verbatim, without further analysis.   
• “Thanks, it’s been helpful.”
• “This was meaningful to
me.” 
• “This is needed in health care.”  
(2 patients)
• “I enjoyed doing it very much,
thanks.” (2 patients)
• “This is an important missing part 
• of health care.”
• “Doing this means you care
deeply for me.”  (2 patients) 
• “This is all humbug.” (His HbA1C
decreased from 10.2 to 8.2)
• “Whatever.”
• “This is good for me.”
• “This was very interesting.”
• “This was very nice.” (2 patients)
• “This was smart to do.”
• “I have to do it for my health
care.”
Discussion
• MOHR was done in person or by 
phone ,but never online
• Mental health diagnoses were not 
addressed specifically as integrated 
PC/MH social worker left the 
practice early in process 
• We had improvement for 8 of 17 
patients with MH comorbidities
• The interventions and outcomes are 
congruent  with findings in the 
literature for a short study
• Positive results with no added costs 
or significant changes in office 
practice.
Conclusions
• Generalizability limited by: small 
sample size; self selected group; 
provider use of motivational 
interviewing and historical patient 
relationships
• Without randomization, 
motivational interviewing, and 
requiring that the MOHR be 
completed we cannot absolutely 
determine the impact of the 
MOHR on T2D disease marker 
improvements. 
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HbA1C Down HbA1c & Wt down
MOHR 10(58%)P=0.02 8(47%) P=0.01
Not 
MOHR
1 (10%) P=0.02 0 (0%)  P=0.01
